reviewThe Spine JournalJun 1, 2011Closed access

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

EJEugene J. CarrageeELEric L. HurwitzBKBradley K. Weiner

Stanford University · Stanford Medicine · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,390
total citations
FWCI
84.75
Percentile
100%
References
88
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Medicine
  • Investigational device exemption
  • Adverse effect
  • Clinical trial
  • Bone morphogenetic protein
  • Spinal fusion
  • Iliac crest
  • Food and drug administration
No related works found for this paper.